Difference between revisions of "Teaching Points"
Jump to navigation
Jump to search
m |
|||
| Line 14: | Line 14: | ||
* [https://pmc.ncbi.nlm.nih.gov/articles/PMC12998346/ Remimazolam targets]: the theoretical initial target concentration of remimazolam may be 0.1 µg/mL for light sedation, 0.2 µg/mL for moderate sedation, and 0.3 µg/mL for deep sedation in elderly patients (70 years), and 1.5 or 2 times those concentrations in middle-aged (45 years) or young adult (20 years) patients. Dose adjust upwards by 10% in females, down by 20% in obesity or ASA III/IV. | * [https://pmc.ncbi.nlm.nih.gov/articles/PMC12998346/ Remimazolam targets]: the theoretical initial target concentration of remimazolam may be 0.1 µg/mL for light sedation, 0.2 µg/mL for moderate sedation, and 0.3 µg/mL for deep sedation in elderly patients (70 years), and 1.5 or 2 times those concentrations in middle-aged (45 years) or young adult (20 years) patients. Dose adjust upwards by 10% in females, down by 20% in obesity or ASA III/IV. | ||
* [[Perioperative HTN]] | * [[Perioperative HTN]] | ||
| − | * | + | * [https://www.cureus.com/articles/241346-comparison-of-different-weight-scalars-to-dose-sugammadex-for-the-reversal-of-neuromuscular-blockade-in-morbidly-obese-patients-a-systematic-review#!/ Sugammadex dosing in obesity] |
Latest revision as of 22:32, 4 November 2026
- DL vs. VL
- Methadone
- Extubation strategy Low vs. High FiO2
- Esmolol vs Fentanyl induction
- Weight scalars
- Tachycardia and Bradycardia algorithms
- Airway anatomy
- Stanpumpr.io / Posology
- Sustainability priorities (N2O, HVAC, LFA, disposable items)
- pEEG
- Ketorolac 15 vs. 30
- Modified Bier block for propofol infusion pain
- Permissive hypercapnia
- Remimazolam targets: the theoretical initial target concentration of remimazolam may be 0.1 µg/mL for light sedation, 0.2 µg/mL for moderate sedation, and 0.3 µg/mL for deep sedation in elderly patients (70 years), and 1.5 or 2 times those concentrations in middle-aged (45 years) or young adult (20 years) patients. Dose adjust upwards by 10% in females, down by 20% in obesity or ASA III/IV.
- Perioperative HTN
- Sugammadex dosing in obesity